Abstract
Application for marketing authorisation if a drug has already received approval under a previous conventional NDA; important drug properties as e.g. toxicity and safety have therefore already been documented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag/Wien
About this chapter
Cite this chapter
Nahler, G. (2009). abbreviated new drug application. In: Dictionary of Pharmaceutical Medicine. Springer, Vienna. https://doi.org/10.1007/978-3-211-89836-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-211-89836-9_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-89835-2
Online ISBN: 978-3-211-89836-9
eBook Packages: MedicineMedicine (R0)